Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal stimulation.
Treatments
Posted inNPR
A sense of foreboding hangs over the National Institutes of Health
There’s widespread confusion and fear among scientists and doctors on the sprawling National Institutes of Health campus and at institutions dependent on the agency’s funding.
Posted inNPR
National Science Foundation freezes grant review in response to Trump executive orders
The National Science Foundation has canceled all grant review panels this week. It’s unclear how long the pause could last.
Posted inNPR
FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its own. It was approved in 2019 to treat severe depression.
Posted inNPR
Cancer deaths are declining, but diagnoses are rising especially among younger women
The American Cancer Society’s report shows a mix of lower death rates and rising cancer incidence rates for some groups, especially younger women.
Posted inNPR
Two Marines spent years firing heavy weapons. Then came headaches and hemorrhage.
Two Marines suspect that years of firing powerful weapons caused them to develop the same rare, and potentially fatal, brain condition.
Posted inNPR
The FDA restricts a psychoactive mushroom used in some edibles
The Food and Drug Administration has told food manufacturers the psychoactive mushroom Amanita muscaria isn’t authorized for food, including edibles, because it doesn’t meet safety standards.
Posted inNPR
For kids with rare genetic disorders, customized CRISPR treatments offer hope
The gene-editing technique is effective for treating some illnesses but it’s been too expensive to consider it for rare conditions. A new approach in the works could make it more widely available.
Posted inNPR
Long COVID patients push to see federal research refocused on treatments
The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to market. Patients and scientists say it’s time to push harder for breakthroughs.
Posted inNPR
Alzheimer’s timeline shows changes start as trickle, become torrent
A study of cells from 84 brains finds that Alzheimer’s has two distinct phases, and that one type of neuron is especially vulnerable.
